The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

October 14, 2023

Study Completion Date

June 30, 2024

Conditions
Immune Thrombocytopenia
Interventions
DRUG

Placebo

Placebo given to subject will be adjusted by body weight (\<10kg, Placebo given to subject will be adjusted by body weight(\<10kg, half a bag, 2 times a day; 10-20kg; 1 bag, 2 times a day; 20-30kg, 1.5 bag, 2 times a day; 30-50kg, 2 bags, 2 times a day; ≥50kg, 3 bags, 2 times a day;) .

DRUG

Huaiqihuang Granule

Huaiqihuang Granule given to subject will be adjusted by body weight (\<10kg, half a bag, 2 times a day; 10-20kg; 1 bag, 2 times a day; 20-30kg, 1.5 bag, 2 times a day; 30-50kg, 2 bags, 2 times a day; ≥50kg, 3 bags, 2 times a day)

Trial Locations (14)

430022

Union Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan

Unknown

Guangzhou Women and Children's Medical Center, Guangzhou

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Wuhan Children's Hospital, Wuhan

Children's Hospital of Nanjing Medical University, Nanjing

Children's Hospital of Soochow University, Suzhou

Jiangxi Provincial Children's Hospital, Nanchang

The Affiliated Hospital of Qingdao University, Qingdao

The Affiliated Hospital of Southwest Medical University, Luzhou

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

Beijing Children's Hospital. Capital Medical University, Beijing

Children's Hospital Capital Institute of Pediatrics, Beijing

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Huazhong University of Science and Technology

OTHER

lead

Qidong Gaitianli Medicines Co., Ltd

INDUSTRY